Vermillion (NASDAQ: VRML) focuses on the discovery, development, and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat, and improve outcomes for patients. Vermillion and its scientific collaborators have diagnostic programs in oncology, hematology, cardiology, and women’s health. Vermillion retains rights to discoveries made for diagnostics development, as well as exclusive rights to license discoveries made during the course of these collaborations. For more information visit the company’s Web site at www.vermillion.com

B. Riley & Co. provides a full array of corporate finance, research, sales, trading, and otcqx dad services to corporate, institutional, and high net worth clients.  Headquartered in Los Angeles, with offices in San Francisco, New York, and Newport Beach, the firm is recognized for its distinguished equity research, merger and acquisitions advisory services, initial and secondary public offerings, and institutional private placements. For more information on B. Riley & Co., visit www.brileyco.com.

Let us hear your thoughts below: